
Will Neuralink begin human clinical trials of its Blindsight vision implant in 2026?
Elon Musk says Neuralink is preparing to begin human trials of Blindsight, a brain implant aimed at restoring vision in people with complete blindness, including those without eyes or optic nerves if the visual cortex is intact. The initial target is low-resolution vision, with improvements over time.
Conditions
Resolves “Yes” if by December 31, 2026, Neuralink officially begins human clinical trials of the Blindsight implant (e.g., first patient implanted or trial registered and initiated), as confirmed by Neuralink, regulators, or major medical/technology media. Otherwise — “No.”
Comments